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ABSTRAK 
WILLADSEN, PETER. 2000. Vaksinasi terhadap lalat Chrysomya bezziana : ringkasan pengetahuan hingga saat ini. Jurnal Ilmu 
Ternak dan Veteriner (Edisi Khusus) 5(3): 201-203. 
Metode pembiakan lalat the Old World Screwworm Chrysomya bezziana dalam laboratorium berskala kecil, produksi 
berbagai stadium lalat berikut jaringan yang dihasilkan yang dapat digunakan untuk studi vaksin dan teknik evaluasi efikasi 
vaksin secara in vitro dan in vivo, telah dikembangkan. Metode-metode tersebut akan dapat diterapkan untuk mempelajari lebih 
lanjut pengendalian lalat screwworm dengan menggunakan berbagai teknologi alternatif. Hasil selama ini menunjukkan adanya 
kemungkinan untuk mengintroduksi efek imunologik secara dramatik lewat pemberian makan larva, mengisolasi dan 
mengkarakterisasi antigen tunggal. Namun, vaksin rekombinan yang diharapkan masih belum dapat dihasilkan. Pemahaman 
tentang efek vaksinasi didiskusikan dan berbagai saran dibuat untuk memberi arah penelitian selanjutnya. 
Kata kunci; Chrysomya bezziana, Old World Screwworm fly, vaksin, antigen rekombinan, domba 
ABSTRACT 
WILLADSEN, PETER. 2000. Vaccination against Chrysomya bezziana:  a summary of current knowledge. Jurnal Ilmu Ternak dan 
Veteriner (Edisi Khusus) 5 (3): 201-203. 
Methods for the culture of the Old World Screwworm Fly Chrysomya bezziana on a small laboratory scale, the production of 
life stages and tissues suitable for vaccine study, and the in vitro and in vivo assessment of vaccine effects have all been 
developed. These methods would be applicable to further studies on screwworm control by many alternative technologies. It has 
been shown to be possible to induce dramatic immunological effects on feeding larvae and to isolate and characterise individual 
antigens. However, a recombinant vaccine remains elusive. Current understanding of the effects of vaccination is discussed and 
suggestions made for possible future research directions. 
Key words: Chrysomya bezziana, Old World screwworm fly, vaccine, recombinant antigen, sheep 
The previous papers in this special edition 
summarise knowledge gained through a four-year 
project investigating the feasibility of vaccinating 
against the screwworm fly, C. bezziana. 
The field of vaccination against ectoparasites is in 
its infancy (WILLADSEN and BILLINGSLEY, 1996; 
WILLADSEN, 1999). Therefore, before such a project 
can be carried out, it is essential to establish and 
validate a range of experimental procedures as 
necessary background for further research. For C. 
bezziana, these procedures included the maintenance of 
a culture of C. bezziana in the laboratory, the 
production of material which acts as a source of 
antigens for the development of prototype vaccines and 
the development bioassays for potential vaccination 
effects. Success in each of these has been reported in 
preceding papers. The culture C. bezziana has been 
established and its viability ensured by the routine 
infusion of wild type flies into the colony. Sources of 
antigenic material, as described in the preceding papers, 
have included first and third instar larvae, larval 
secretory/excretory material, larval cardia and larval 
peritrophic membrane. Two assays for vaccine effects 
have been developed. The first measures the direct 
effect of serum on the growth and viability of larvae in 
an in vitro system. The second is an in vivo assay of 
larval growth and survival which exposes the larvae to 
the full immune response of the host as well as the 
physiological differences of individual sheep in an 
outbred population. These techniques are of generic 
applicability, not only to the quantitation of 
immunological effects on screwworm but also for the 
assessment of alternative control technologies. 
With these techniques established, it was possible to 
examine the feasibility of vaccination. It is worthwhile 
briefly summarising the results described in detail in the 
preceding papers. The most effective vaccinations were 
with native whole peritrophic membrane. Here, in vitro 
results showed, on average, a 73% decrease in larval 
weights and a 32% decrease in larval survival, an 
overall decrease in the weight of larvae recovered of 
82%. In vivo, the results were less dramatic but still 
striking: a 41% decrease in larval weights and a 13% 
decrease in larval survival (SUKARSIH et al., 2000). The 
efficacy on some individual sheep was much greater, 
and no attempt has been made at any stage to optimise 
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the immunological responses. The effects after 
vaccination with cardia were less impressive as 
measured in vitro, though the in vivo results were 
comparable with those of the peritrophic membrane 
vaccinates. Extracts of whole first and third instar 
larvae were assessed only in vitro and, though they gave 
some inhibition of larval growth, these immunogens 
were not studied further. Vaccination with serine 
proteases from secretory/excretory material showed no 
effect in vitro but a significant reduction in growth 
coupled with an increased survival in vivo. Vaccinations 
with peritrophic membrane fractions were, in general, 
less effective than the full membrane, while vaccination 
with recombinant versions of individual peritrophic 
membrane proteins either showed no effect or a slight 
exacerbation of the infestation. 
The challenge is to draw these observations together 
into a pattern that might lead to productive future 
research. 
The first lesson is that both in vitro and in vivo assay 
systems have a role to play in any future work. The fact 
that the results of the two assays are, in many instances, 
not directly comparable demonstrates that important 
biological information can be obtained from each of 
them. For example, in two experiments, accurate 
weights for larvae feeding in vitro and in vivo on 
individual sheep vaccinated with whole peritrophic 
membrane were obtained. These weights showed no 
significant rank correlation, possibly due to differences 
in feeding physiology and immunological reactions in 
the two systems. In the final analysis, it will always be 
the results in vivo which are critical for the development 
of a vaccine. 
When the project began, the only myiasis fly that 
had been investigated in any detail was L. cuprina. 
Superficially, the feeding behaviour of L. cuprina and 
C. bezziana is similar. It is important therefore to 
recognise that the current research has shown the 
dangers of extrapolating from one parasite to the other. 
With L. cuprina, in vitro and in vivo assays are 
generally correlated. As above, with C. bezziana, this is 
not the case. With L. cuprina, the effects of vaccinating 
with proteases have been equivocal. With C. bezziana, 
the results are more significant, even if they appear at 
first sight to be contradictory, a mixture of effects 
which simultaneously inhibit growth but slightly 
enhance survival. With both parasites the peritrophic 
membrane is the most effective source of protective 
antigens. In both parasites, there is a correlation 
between larval weights and larval survival in the in 
vitro assays, suggesting similar effects might be 
occurring. In C. bezziana, this correlation is not found 
in vivo. In L. cuprina, the effect appears to be due to 
blockage of the peritrophic membrane by the binding of 
antibody. Whether this is the case with C. bezziana is 
unknown. 
The interaction between any pathogenic organism 
and the immune system is enormously complex. It is 
well recognised that this interaction can lead to both 
protection and the exacerbation of disease or pathology. 
Much attention has focused on the various arms of the 
immunological response, as exemplified by Th1 and 
Th2 paradigm in rodents and humans. In working with 
complex parasites and parasite extracts, as with C. 
bezziana, there is an added complexity in that the host 
is exposed to a very large number of immunogenic 
molecules during vaccination, some of which are likely 
to be appropriate targets for a protective response, while 
others might, through the interaction with the immune 
system, stimulate pathology or facilitate parasite 
development. 
The current work provides evidence for both 
protection and exacerbation of disease. With the limited 
evidence currently available, the factors which facilitate 
larval survival and those which inhibit larval growth 
and decrease survival are equally a matter of 
speculation. Nevertheless, such speculation is important 
since it may suggest directions for further research. 
There are two lines of evidence suggesting that 
exacerbation of the infection can occur or, at least, can 
be an environment advantageous to the larvae generated 
through the induction of an immunological response. 
Firstly, there is a positive correlation between antibody 
titre to the SDS soluble immunogens from the 
peritrophic membrane and the weight of larvae 
recovered in vitro (SUKARSIH et al., 2000). Secondly, an 
increase in larval recovery in vivo occurs following 
vaccination with proteases and recombinant PM 48 
expressed in Pichia. It is important that these effects, 
though scientifically interesting, appear to also be 
quantitatively small. 
Consider the increased larval survival from sheep 
vaccinated with some antigens. One explanation might 
be an increased inflammatory response in vaccinated 
sheep. Feeding larvae of C. bezziana cause wound 
inflammation, probably made worse by the concomitant 
bacterial infections. If an immunological response adds 
to the inflammation, this may be to the advantage of the 
parasite. The peritrophic membrane is excreted 
continuously by larvae and so must be present in the 
wound. Alternatively, some of the proteins from the 
membrane may also exist in soluble form, even though 
they were obtained experimentally by extraction with 
detergents or denaturants. The PM95 antigen from L. 
cuprina, which experimentally is only solubilized in 8M 
urea, is also found in a soluble form in excretory/ 
secretory material (TELLAM et al., 2000). Nevertheless, 
current evidence is that Cb42, Cb48 and Cb15 all fail to 
stimulate a significant immunological response in sheep 
exposed to C. bezziana infections under natural 
conditions. 
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It is also difficult to understand the results from 
vaccination with proteases. One can imagine that 
antibody to proteases may inhibit growth either directly 
or through inhibiting wound development but it is 
harder to see why this inhibition of growth is 
accompanied by higher larval recovery. Again, it must 
be remembered that the increases in larval recovery, 
though statistically significant, are relatively small. 
Far more importantly, immunological inhibition of 
larval growth and survival was the aim of this project. 
This has been found. Protection is seen in the 
vaccination with peritrophic membrane, inhibition of 
growth by vaccination with proteases, vaccination with 
cardia, and, to a lesser extent, through the in vitro 
results of vaccinating with fractions derived from the 
peritrophic membrane. The results still fall short of an 
effective vaccine, though it must be remembered that 
even the in vivo assay system is still only a model for a 
true, natural infection, severely limited in duration and 
effect on the host on ethical grounds and for reasons of 
experimental reproducibility. It is possible that a longer 
exposure to the host’s immune system may also lead to 
greater larval mortality, while limitation of wound 
development by vaccination may limit the successive 
cycles of egg laying and larval infection that typify a 
field infestation. This is currently a matter for 
speculation. 
It would be desirable to clarify the mechanism of 
those effects that have been observed. Research with L. 
cuprina suggested a simple mechanism, blockage of the 
peritrophic membrane by antibody (CASU et al., 1997; 
TELLAM and EISEMANN, 1998) which may well not 
obtain with C. bezziana. The evidence against it is 
tentative. With L. cuprina, this mechanism leads to 
clear effects in vitro, since it depends solely on 
antibody. For C. bezziana, although the whole 
peritrophic membrane has been found to be an effective 
immunogen, the results of vaccination with 
recombinant versions some of the major peritrophic 
membrane proteins have been negative although the 
antibodies bind to the peritrophic membrane. It may be, 
for example, that the size of pores in the peritrophic 
membrane of C. bezziana is such that blockage is more 
difficult to achieve. These factors can be addressed 
experimentally and to do so would be illuminating. 
If simple blockage of the peritrophic membrane is 
not the mechanism of immune protection, then the 
protection that has been observed with some fractions 
may be due to more specific, more functional 
interaction between the immune system and the 
parasite. This is an exciting possibility, since it suggests 
that better immunological protection might be achieved 
if such functionally important targets could be 
identified. 
The experimental difficulties in doing so are 
formidable. The target antigens may be minor rather 
than major components of the immunogenic extracts 
use to date; it would be necessary to disentangle the 
protective responses from those that enhance survival 
and much of the experimentation would rely on of the 
use of in vivo assays. Nevertheless, could this be 
achieved, the results would be of great scientific interest 
and considerable practical value in animal production 
systems in large areas of the tropical and sub-tropical 
world. 
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